Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma

Summary

RATIONALE: Current therapies for adult recurrent/progressive oligodendrogliomas provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of childhood brain tumors. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on adult recurrent/progressive oligodendrogliomas.

Timeline

Start

1996-05

Primary completion

2007-09

Completion

2007-09

Drugs

Indications